Correction: Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

In the original version of this article (1), Fig. 2C, the left-most image in row 5 representing the day 30 time point for the group of mice treated with BCMA-41BBζ[2A]GPRC5D-CD28ζ was inadvertently duplicated to row 4 representing the same time point for the mice treated with GPRCD-BCMA-41BBζ. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.